MARKET

MGTX

MGTX

MeiraGTx Holdings plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.14
-0.49
-3.14%
After Hours: 15.14 0 0.00% 16:00 01/25 EST
OPEN
15.51
PREV CLOSE
15.63
HIGH
15.61
LOW
14.80
VOLUME
146.52K
TURNOVER
--
52 WEEK HIGH
21.77
52 WEEK LOW
8.82
MARKET CAP
668.62M
P/E (TTM)
-10.5183
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 16)
Benzinga · 12/17/2020 13:10
MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia
Webcast and conference call to take place on December 17, 2020 at 8:00 a.m. ET
Globe Newswire · 12/16/2020 21:30
MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia
Webcast and conference call to take place on December 17, 2020 at 8:00 a.m. ETLONDON and NEW YORK, Dec. 16, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Com...
GlobeNewswire · 12/16/2020 21:30
Is MGTX A Good Stock To Buy Now?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are indust...
Insider Monkey · 12/13/2020 02:48
MeiraGTx to Participate in the Evercore ISI 3rd Annual HealthCONx Conference
MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer, will present at the Evercore ISI 3 Annual HealthCONx Conference at 10:...
GlobeNewswire · 12/01/2020 17:19
MeiraGTx to Participate in the Evercore ISI 3rd Annual HealthCONx Conference
GlobeNewswire · 11/30/2020 21:30
Insider Buys MeiraGTx Stock
Shares of MeiraGTx Hldgs Inc (NASDAQ:MGTX) gained by 5.7% from the previous closing price. Perceptive Advisors Llc filed a Form 4 with the SEC on Tuesday, November 24. The insider bought 500,000 shares at an average price of $12.85. After the transaction, the executive's stake in MeiraGTx Hldgs Inc.
Benzinga · 11/24/2020 16:34
Insider Buys MeiraGTx Stock
Benzinga · 11/24/2020 16:34
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MGTX. Analyze the recent business situations of MeiraGTx Holdings plc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MGTX stock price target is 36.17 with a high estimate of 55.00 and a low estimate of 24.00.
EPS
Institutional Holdings
Institutions: 132
Institutional Holdings: 22.26M
% Owned: 50.40%
Shares Outstanding: 44.16M
TypeInstitutionsShares
Increased
20
549.58K
New
25
1.16M
Decreased
33
475.57K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.71%
Pharmaceuticals & Medical Research
+1.12%
Key Executives
Chairman/Independent Director
Keith Harris
President/Chief Executive Officer/Director
Alexandria Forbes
Chief Financial Officer/Chief Operating Officer
Richard Giroux
Other
Stuart Naylor
Independent Director
Ellen Hukkelhoven
Independent Director
Martin Indyk
Independent Director
Arnold Levine
Independent Director
Joel Marcus
Independent Director
Neil Mendoza
Independent Director
Nicole Seligman
Independent Director
Thomas Shenk
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About MGTX
MeiraGTx Holdings plc is a clinical-stage gene therapy company. The Company develops gene therapy treatments for a range of inherited and acquired disorders. It is focused on developing therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia, radiation treatment for head and neck cancers and neurodegenerative diseases, such as amyothrophic lateral sclerosis (ALS). It is also developing transformative technology to enable the use of small molecules to turn gene therapy product candidates on and off. It is focused on three areas of unmet medical needs, including inherited retinal diseases, severe forms of xerostomia and neurodegenerative diseases. Its product candidates include AAV-CNGB3, AAV-CNGA3, AAV-RPGR, AAV-RPE65, AAV-AQP1 and AAV-UPF1.
More

Webull offers kinds of MeiraGTx Holdings PLC stock information, including NASDAQ:MGTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MGTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MGTX stock methods without spending real money on the virtual paper trading platform.